• Increase font size
  • Default font size
  • Decrease font size
Interview with Dr. William Carter, CEO of Hemispherx Biopharma PDF  | Print |  E-mail
Written by M.E.Garza   
Friday, 09 October 2009 00:00


An interview with Dr. William Carter, CEO of Hemispherx Biopharma (AMEX:HEB) regarding the status of the NDA for Ampligen as a first line treatment for Chronic Fatigue Syndrome as well as his company's pipeline plans for Alferon LDO (Low Dose Oral) application.

Related Materials

PR: Stanford University Presents New Data On Immuno-Potential of Hemispherx's Ampligen

HEB's Latest Form 10-Q - Quarterly report

Maxim Conference Presentation Webcast

During the interview, there are references made to various materials which can be found/downloaded/seen via the links on the right.

The audio interview with Dr. Carter can be heard below:

 

 

 

 

 

Disclosure: No Positions

 

 

 

 





BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
Trackback(0)
Comments (11)add comment

pc10092009 said:

...
When does HEB know about the issue regarding the facility? According to previous interview/conference, there is no issue at all. I remember someone in yahoo message board has mentioned the issue about the facility few weeks ago based on one of HEB's filing.
 
October 09, 2009
Votes: +1

ThomasHEB said:

...
It might be helpful to write a short article that sums up some of the main points of what Dr. Carter said in the interview. Few people have the time to listen to a 18 minutes long interview.
 
October 09, 2009
Votes: +0

pc10092009 said:

...
I actually posted this thread in yahoo: http://messages.finance.yahoo....ts/Stocks_(A_to_Z)/Stocks_H/threadview?bn=27865&tid=298361&mid=298361

It looks like the same facility issue mentioned in today's interview. Am I right?
 
October 09, 2009
Votes: +1

pc10092009 said:

...
Hi M.E. Garza,

I wonder why HEB does not talk about the cause of the delay until now.

Did you read that 10Q when it was available months ago? I have to assume that you have read it and you have notice those paragraphs about the facility.

The situation makes me very skeptical of HEB and BioMedReports.
 
October 09, 2009
Votes: +0

JB said:

...
Carter fumbled this one unfortunately. I am amazed that he has stayed in business for so long. From the website on down this company is amateur. Look at CYCC, nice professional website, well spoken CEO and a clear/concise product pipeline. This is what HEB should emulate.
 
October 09, 2009
Votes: +0

Peter said:

...
Great interview...

So, M.E. Garza, what is your take on the interview...

Was it right/legal for Dr. Carter to fail to reveal the truth behind the "1-2 week wait"?

I will be holding onto this stock but there is no doubt in my mind that I will be holding it until early 2010 or maybe even later.

What I got from the interview:

They have to complete these compliances.

Then they have to file them with the FDA.

Then the FDA has to evaluate these findings.

I do not see approval "any day" as the "FDA wait" anymore.

This is hugely upsetting that the CEO has "hidden" the fact that this was what was most likely holding up the approval.

I know it was in a SEC filing, but until now, Dr. Carter has persistently refused to admit any reason for the hold up other than it being such a serious decision that takes time.

It wasn't that he didn't want to contact the FDA and cause some kind of rift between Hemispherx and the FDA...

...it was that he knew what was holding up the approval. And with this knowledge he has fooled the investors into believing that approval could happen in 1-2weeks or even any-day approvals...

But that is not the case...

My sentiment...

Play the stock for now... Sell when it spikes buy when it dips.

But when mid-december rolls around... I would get back in to hold for the big profit to come.
 
October 09, 2009
Votes: +1

rgard32 said:

...
If you look at the OLD 10Q from may the lovelace tox issues were still there.. THIS HAD ZERO CHANCE of approval back in may and CARTER KNEW IT.....LOL i cant wait for this thing to end so someone can make a movie about this 30 yr old scam hahaha.
 
October 09, 2009
Votes: +0

R5c9t1 said:

...
If it was up to traders, they would require news every day, no time to waste, need to make money to feel grand !!! Unfortunately things in real life, I mean the life of those who do have some job, and some task to accomplish, a project to complete, are different. It takes time to get some real progress, it takes time to test, prove, or disprove hypotheses and facts.

Get out this sector, let people do their work and find drugs which can be used to cure the needy. Go gamble with your money on some less sensitive area, the market has plenty of other opportunities for all sorts of taste.

And say hallo to Ascensio for me, tell him I hope he dropped dead.
 
October 10, 2009
Votes: +1

England,uk said:

...
I'm ill. I need this medicine. I have chronic fatigue syndrome. Been I'll since I was 14 years old I'm now 24. Please get this medicine sorted out. Every year that goes by is my life being taken away. Please someone out there work hard to get this medicine approved. I have tried EVERYTHING to get well. I cannot do it my self. I've tried diet, exercise, rest, sleep, worked so hard to try and get over the 5 viruses I had, but somethings wrong with my body that I alone cannot fix......Please for goodness sake forget the money and do it for the people. We need this!
 
October 12, 2009
Votes: +1

olivier roland said:

...
Hi Mr Garza,

When Dr. Carter said "until all these documents are filed [meaning the tox tests and the facility thing], the FDA CAN withhold a decision." At this time, you should have asked him: "can they really give a decision before all these documents are properly filed?" This is the critical issue and Carter likes to play with words to keep his stock high.

Besides this point, I do feel that ampligen will be approved, the question remains when.

 
October 15, 2009
Votes: +0

rgard40 said:

...
WOW listening to this now..all you hear is LIES... alferon LDO phase 2-3 trials start in december? LMFAO
 
January 12, 2010
Votes: +0

Write comment
smaller | bigger

busy
Last Updated on Friday, 09 October 2009 05:36
 

Sign Up For Phone Alerts